Drug Trial Radar · NCT07100119
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Aug 5, 2025
Primary completion
Aug 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Aug 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate how well LY4256984 is tolerated and what side effects may occur in participants with sporadic amyotrophic lateral sclerosis (ALS). The study drug will be administered intrathecally (IT) into the spine. Blood tests will be performed to check how much LY4256984 gets into the bloodstream and how long it takes the body to eliminate it.
Conditions
- ALS (Amyotrophic Lateral Sclerosis)
Interventions
LY4256984Drug
Administered IT
PlaceboDrug
Administered IT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs), Serious Adverse Event(s) (SAEs), and Adverse Event(s) (AEs) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline up to Approximately Day 253
Locations
12 sites in 5 countries. Site status is shown where the registry gives one.
UZ Leuven
Leuven, Belgium · Recruiting
Heritage Medical Research Clinic
Calgary, Canada · Recruiting
Walter Mackenzie Health Sciences Centre
Edmonton, Canada · Not yet recruiting
London Health Sciences Centre
London, Canada · Recruiting
Montreal Neurological Institute and Hospital
Montreal, Canada · Recruiting
Sunnybrook Research Institute
Toronto, Canada · Recruiting
Universitätsklinikum Schleswig-Holstein
Lübeck, Germany · Recruiting
Universitätsmedizin Rostock Sektion für Translationale Neurodegeneration "Albrecht Kossel" Klinik und Poliklinik für Neurologie
Rostock, Germany · Not yet recruiting
Universitätsklinikum Ulm
Ulm, Germany · Recruiting
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands · Recruiting
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Spain · Recruiting
Hospital Universitari i Politecnic La Fe
Valencia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.